PTH(1-84) replacement therapy in hypoparathyroidism: A randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment-Reference-Cited by-同舟云学术

PTH(1-84) replacement therapy in hypoparathyroidism: A randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment

Published:2013-09-18 Issue:10 Volume:28 Page:2232-2243
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Sikjaer Tanja¹,Amstrup Anne Kristine¹,Rolighed Lars²,Kjaer Soren Geill³,Mosekilde Leif¹,Rejnmark Lars¹

Affiliation:

1. Department of Endocrinology and Internal Medicine; MEA, Aarhus University Hospital; Aarhus Denmark

2. Department of Surgery P; Aarhus University Hospital; Aarhus Denmark

3. Department of Internal Medicine; Silkeborg Regional Hospital; Silkeborg Denmark

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.1964/fullpdf

Reference34 articles.

1. Clinical practice. Hypoparathyroidism;Shoback;N Engl J Med.,2008

2. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism;Winer;JAMA.,1996

3. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism;Winer;J Clin Endocrinol Metab.,1998

4. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium;Winer;J Clin Endocrinol Metab.,2003

5. Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism;Winer;J Clin Endocrinol Metab.,2008

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical development of EXT608, an investigational parathyroid hormone derivative with extended half-life for the treatment of hypoparathyroidism;JBMR Plus;2024-04-18

2. Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1–84) in hypoparathyroidism;JBMR Plus;2024-01-05

3. Transitory Activation and Improved Transition from Erosion to Formation within Intracortical Bone Remodeling in Hypoparathyroid Patients Treated with rhPTH(1–84);JBMR Plus;2023-11-17

4. Parathyroid diseases and metabolic syndrome;Journal of Endocrinological Investigation;2023-02-11

5. Management of Post-operative Hypocalcemia;Practical Management of Thyroid Cancer;2023